Indefinite Delivery Contract 36C24823D0058

The U.S. Department of Veterans Affairs (VA) has awarded a series of firm-fixed-price delivery orders under a single indefinite delivery contract (IDC) to Abbott Laboratories Inc., a global healthcare company, to provide a variety of COVID-19 testing products and services. These include SARS serology reagent test kits, SARS COV-2 testing services, and COVID-19 testing reagents and supplies. The delivery orders, valued at over $4.8 million in total, will support the VA's Veterans Integrated Service Network 8, which covers healthcare facilities in the Midwest region. Abbott Laboratories, through its Abbott Diagnostics Division, has an established track record of providing diagnostic equipment, testing supplies, and related services to the VA and other federal agencies to enable their clinical laboratory operations. The delivery orders leverage existing contract vehicles like the company's General Services Administration Federal Supply Schedule to allow the VA to rapidly fulfill its pandemic response requirements.

The original solicitation indicates the VA's intent to sole-source these COVID-19 testing products and services to Abbott Laboratories due to the compatibility of the company's ARCHITECT and Alinity analyzers and reagents with the VA's existing laboratory infrastructure. No set-aside designations were used for these awards. The contracts will be performed primarily at Abbott's facilities in North Chicago, Illinois, as well as in support of VA hospitals and clinics in Florida. This procurement supports the VA's ongoing efforts to monitor the COVID-19 pandemic among the veteran population through serology and other diagnostic testing.